Rogers L R
Wayne State University School of Medicine, University Health Center, Detroit, Michigan.
Oncology (Williston Park). 1994 Jun;8(6):23-30; discussion 31-2, 37.
Cerebrovascular disorders often complicate the clinical course of a variety of solid tumors and hematologic/lymphoreticular malignancies. In rare instances, cerebrovascular disease is the presenting sign of cancer. Cerebral hemorrhages are more common in leukemia, and infarctions are more common in lymphoma and solid tumors. The usual causes of stroke are the direct effects of tumor in the brain or adjacent structures, coagulation disorders, infection, or toxicity of antineoplastic therapy. The type of systemic cancer, the extent of systemic and central nervous system metastasis, and the type of antineoplastic treatment are the most important clues in determining the etiology of cerebrovascular disease in cancer patients. Neuroimaging studies often assist in diagnosis and disease localization. Coagulation function tests are most useful in identifying coagulopathies associated with hemorrhage.
脑血管疾病常使各种实体瘤及血液系统/淋巴网状系统恶性肿瘤的临床病程复杂化。在罕见情况下,脑血管疾病是癌症的首发症状。脑出血在白血病中更常见,而梗死在淋巴瘤和实体瘤中更常见。中风的常见病因是肿瘤对脑或邻近结构的直接影响、凝血功能障碍、感染或抗肿瘤治疗的毒性作用。全身性癌症的类型、全身及中枢神经系统转移的程度以及抗肿瘤治疗的类型是确定癌症患者脑血管疾病病因的最重要线索。神经影像学检查常有助于诊断和疾病定位。凝血功能检查在识别与出血相关的凝血障碍方面最为有用。